<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bcl10 is a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> gene recently identified in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of mucosa-associated lymphoid tissues </plain></SENT>
<SENT sid="1" pm="."><plain>It has been suggested as a target for mutation in multiple types of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> including follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, T-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:e sem="disease" ids="C0036920" disease_type="Neoplastic Process" abbrv="">Sezary syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To evaluate further the role of Bcl10 in human adult haematological <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, we screened for mutations samples from 24 patients with B-cell <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL) and 18 samples from patients with T-cell prolymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (T-<z:chebi fb="1" ids="53412">PLL</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>No pathogenic mutations were detected in any of the samples analysed, strongly suggesting that Bcl10 is not involved in the development of CLL or T-<z:chebi fb="1" ids="53412">PLL</z:chebi> and that its involvement may be restricted to other <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> </plain></SENT>
</text></document>